No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SAGAU Sagaliam Acquisition Corp.
- 10.940
- 0.0000.00%
Close Mar 7 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open10.940Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares11.27052wk High0.00P/B0Float Cap10.94052wk Low--Dividend TTM0Shs Float11.740Historical High--Div YieldTTM0.00%Amplitude9.900Historical Low--Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
No Data
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release
Express News | Sagaliam Acquisition Corp: "Statements in Nika Press Release Are Incorrect"
Express News | Sagaliam Acquisition Corp: Virogentics Inc Holds Exclusive Worldwide License for Itv-1 and Is Sole Owner of Trade Secrets Needed to Produce Treatment
Sagaliam Acquisition Corp Launches Improved IPF Formula With Vitamin C in Pill and Lozenge Form and Addition of New Slimming Neutraceutical
Sagaliam Acquisition Corp. Announces Novation Agreement With Enzolytics, Inc.
Sagaliam Acquisition Corp.'s Nasdaq Delisting and OTC Transition
Heat List
US
Overall
Symbol
Price
% Chg
No Data